Skip to main content
一致魔芋 logo

一致魔芋 — Investor Relations & Filings

Ticker · 920273 ISIN · CNE100005SP4 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 449 across all filing types
Latest filing 2023-03-22 Capital/Financing Update
Country CN China
Listing Beijing Stock Exchange 920273

About 一致魔芋

http://www.easykonjac.com/

Hubei Yizhi Konjac Biotechnology Co., Ltd. specializes in the research, development, and large-scale production of konjac-based ingredients and consumer products. The company’s core portfolio includes konjac flour, purified glucomannan, and dietary fibers utilized as functional additives, stabilizers, and gelling agents. Beyond food applications, it develops specialized konjac derivatives for the cosmetic and pharmaceutical sectors, including biodegradable materials and moisturizing components. The firm maintains an integrated industrial chain encompassing raw material sourcing and advanced deep-processing technologies. Its products are designed to meet global standards for health-oriented applications, focusing on low-calorie, high-fiber solutions for weight management and digestive wellness. Through continuous biotechnological innovation, the company provides versatile raw materials and finished goods to diverse international markets.

Recent filings

Filing Released Lang Actions
关于使用募集资金向全资子公司增资实施募投项目的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the use of raised funds (募集资金) by the company 湖北一致魔芋生物科技股份有限公司 to increase capital in its wholly-owned subsidiary for implementing investment projects. It details the fundraising approval by the China Securities Regulatory Commission, the issuance and listing of shares, the amount of funds raised, and the specific use of these funds. It also includes board and independent director opinions and mentions relevant regulatory approvals and compliance with listing rules. The document is not a full financial report but an announcement about capital use and fundraising activities. It is relatively short (3263 characters) and focuses on capital usage and financing updates rather than financial results or management discussion. Therefore, it fits best under Capital/Financing Update (CAP).
2023-03-22 Chinese
内控鉴证报告
Regulatory Filings
2023-03-22 Chinese
董事会审计委员会2022年度履职情况报告
Audit Report / Information Classification · 95% confidence The document is titled as a "Board Audit Committee 2022 Annual Performance Report" from Hubei Yizhi Konjac Biotechnology Co., Ltd. It details the audit committee's activities, meetings, supervision of external auditors, review of financial reports, internal audit guidance, internal control evaluation, and related party transactions for the year 2022. The content is a detailed report on the audit committee's duties and findings for the year, not a full annual report or standalone audit report. It is not an announcement or certification but a substantive report on audit committee activities and oversight. This fits best under the category of Audit Report / Information (AR), which includes audit reports and related internal control and audit committee information, excluding full annual reports. The document length (2603 characters) is sufficient for a detailed report but not a full annual report. Therefore, the classification is AR with high confidence. FY 2022
2023-03-22 Chinese
天健会计师事务所（特殊普通合伙）关于湖北一致魔芋生物科技股份有限公司以自筹资金预先投入募投项目及支付发行费用的鉴证报告
Regulatory Filings
2023-03-22 Chinese
2022年年度度权益分派预案公告
Notice of Dividend Amount Classification · 95% confidence The document is a detailed announcement regarding the company's 2022 annual profit distribution plan (dividend distribution plan). It includes specifics about the dividend amount, the board and supervisory committee approvals, references to the company's articles of association regarding profit distribution, and the upcoming shareholder meeting approval. The document does not contain full financial statements or comprehensive financial performance data but focuses on the dividend proposal and related corporate governance procedures. It is not an annual report, earnings release, or management report. It is also not a simple announcement of a report publication but a substantive announcement about dividend distribution. Therefore, the document fits best under the category of Notice of Dividend Amount (DIV).
2023-03-22 Chinese
2022年度内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2022 年度内部控制自我评价报告' which translates to '2022 Annual Internal Control Self-Evaluation Report'. It discusses the company's internal control evaluation for the fiscal year ending December 31, 2022, including detailed descriptions of internal control elements, risk assessment, control activities, and planned improvements. The content focuses on internal control effectiveness and compliance with regulatory standards, which aligns with an Audit Report or Information type document rather than a full Annual Report or other categories. The document length is 5889 characters, sufficient to contain substantive content rather than a brief announcement. There is no indication that this is a certification letter or a report publication announcement. Therefore, the document fits best under the Audit Report / Information (AR) category. FY 2022
2023-03-22 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.